Ki Summary

Reaction Details

Report a problem with these data

Target

Serine/threonine-protein kinase B-raf

Ligand

BDBM50303111

Substrate/Competitor

n/a

Meas. Tech.

ChEMBL_597720 (CHEMBL1043507)

IC50

2.1±n/a nM

Citation

Di Grandi, MJ; Berger, DM; Hopper, DW; Zhang, C; Dutia, M; Dunnick, AL; Torres, N; Levin, JI; Diamantidis, G; Zapf, CW; Bloom, JD; Hu, Y; Powell, D; Wojciechowicz, D; Collins, K; Frommer, E Novel pyrazolopyrimidines as highly potent B-Raf inhibitors. Bioorg Med Chem Lett19:6957-61 (2009) [PubMed] Article

More Info.:

Get all data from this article, Assay Method

Serine/threonine-protein kinase B-raf

Name:

Serine/threonine-protein kinase B-raf

Synonyms:

Type:

Serine/threonine-protein kinase

Mol. Mass.:

84446.00

Organism:

Homo sapiens (Human)

Description:

P15056

Residue:

766

Sequence:

MAALSGGGGGGAEPGQALFNGDMEPEAGAGAGAAASSAADPAIPEEVWNIKQMIKLTQEH
IEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSSASMDTV
TSSSSSSLSVLPSSLSVFQNPTDVARSNPKSPQKPIVRVFLPNKQRTVVPARCGVTVRDS
LKKALMMRGLIPECCAVYRIQDGEKKPIGWDTDISWLTGEELHVEVLENVPLTTHNFVRK
TFFTLAFCDFCRKLLFQGFRCQTCGYKFHQRCSTEVPLMCVNYDQLDLLFVSKFFEHHPI
PQEEASLAETALTSGSSPSAPASDSIGPQILTSPSPSKSIPIPQPFRPADEDHRNQFGQR
DRSSSAPNVHINTIEPVNIDDLIRDQGFRGDGGSTTGLSATPPASLPGSLTNVKALQKSP
GPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDV
AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHH
LHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV
KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN
NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS
LPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH

BDBM50303111

n/a

Name

BDBM50303111

Synonyms:

(2R)-1-(3-(3-(1H-indazol-4-yl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)-8-azabicyclo[3.2.1]octane-8-carbonyl)pyrrolidine-2-carboxylic acid | CHEMBL571748

Type

Small organic molecule

Emp. Form.

C31H30N8O3

Mol. Mass.

562.6217

SMILES

OC(=O)[C@H]1CCCN1C(=O)N1C2CCC1CC(C2)c1ccnc2c(c(nn12)-c1ccncc1)-c1cccc2[nH]ncc12 |r,wU:3.2,THB:18:16:10:12.13,(28.67,-19.29,;28.61,-20.83,;27.25,-21.54,;29.91,-21.65,;31.37,-21.16,;32.29,-22.4,;31.39,-23.66,;29.92,-23.2,;28.69,-24.11,;27.34,-23.37,;28.71,-25.65,;28.18,-27.12,;26.66,-27.8,;28.03,-27.77,;29.22,-26.9,;30.76,-27.75,;30.22,-29.22,;29.78,-28.03,;30.22,-30.76,;28.89,-31.53,;28.89,-33.08,;30.23,-33.85,;31.56,-33.08,;33.03,-33.55,;33.94,-32.3,;33.03,-31.05,;31.56,-31.53,;35.48,-32.3,;36.25,-33.63,;37.79,-33.63,;38.56,-32.3,;37.78,-30.96,;36.24,-30.97,;33.1,-35.09,;31.8,-35.91,;31.86,-37.45,;33.22,-38.17,;34.53,-37.35,;36.03,-37.76,;36.88,-36.47,;35.91,-35.26,;34.46,-35.8,)|

Structure